Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
Andrew Hantel(Harvard University), Gregory A. Abel(Dana-Farber Cancer Institute), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Wendy Stock(University of Chicago), Marlise R. Luskin(Dana-Farber Cancer Institute), Daniel J. DeAngelo(Dana-Farber Cancer Institute)
Cited by 38
Related Papers
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464